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UV-irradiation at 365 nm of cultured Cloudman S91 mouse melanoma cells in the presence of photoreactive 
a-MSH analogues induced longlasting receptor stimulation as revealed by the ensuing activation of tyrosin- 
ase. Receptor labelling was more efficient with 4-diazirinophenyl and 2-nitro-4-azidophenyl photolabels 
than with 4-azidophenyl, and was further increased when superpotent [Nle4,D-Phe’]-cc-MSH was used as 
ligand. Incubation of B16 melanoma cell membranes with mono-iodinated [Nle4,D-Phe7,Trp-(Naps)9]-a- 
MSH followed by UV-irradiation at 31&550 nm labelled a single band on SDS-PAGE with a molecular 
mass = 45 kDa. The displacement curve obtained in a competitive photolabelling experiment paralleled 
that of the binding assay, demonstrating that the labelling was specific. 
Photoaffinity labeling; Carbene; Nitrene; Melanocyte-stimulating hormone receptor; 
(Cloudman S91 mouse melanoma cell, B16 mouse melanoma cell) 
1. INTRODUCTION 
a-Melanocyte-stimulating hormone (a-melano- 
tropin) is well known to induce pigment dispersion 
in melanophores of lower vertebrates and to have 
neurotrophic and other functions in the nervous 
system (reviewed in [I]). The hormone also 
stimulates melanogenesis in mammalian melano- 
cytes and melanoma cells by activating tyrosinase, 
the rate-limiting enzyme for melanin formation 
Correspondence address: A.N. Eberle, Department of 
Research (ZLF), University Hospital, Hebelstrasse 20, 
CH-403 1 Basel, Switzerland 
Abbreviations: MSH, melanocyte-stimulating hormone 
(melanotropin); PAGE, polyacrylamide gel elec- 
trophoresis; photolabels: Apac, 4-azidophenylacetyl; 
Naps, 2-nitro-4-azidophenylsulfenyl; Tdbz, 4-(3-tri- 
fluoromethyldiazirino)benzoyl 
This paper is dedicated to Professor Alfred Pletscher on 
the occasion of his 70th birthday 
[l]. The hormone acts through a specific mem- 
brane receptor which has been characterized exten- 
sively by structure-activity and binding studies 
[l-3]. 
Photoaffinity labelling has become an important 
technique for the localization and characterization 
of peptide hormone receptors and for functional 
studies [4]. The method has previously been ap- 
plied to MSH receptors on frog and lizard 
melanophores, which are irreversibly stimulated 
after formation of a covalent hormone-receptor 
complex [5,6], and to the analysis of factors par- 
ticipating in the signal transduction through the 
membrane [7,8]. The present report describes the 
labelling of MSH receptors on intact Cloudman 
S91 mouse melanoma cells using nitrene- and 
carbene-generating photolabels attached to natural 
a-MSH and superpotent [Nle4,D-Phe’]-cY-MSH. 
Based on these functional studies, the most 
suitable photoreactive a-MSH derivative was 
selected for biochemical analysis of the MSH 
receptor on plasma membranes of B16 mouse 
melanoma cells. 
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2. MATERIALS AND METHODS 
2.1. Peptides 
The synthesis of the photoreactive analogues of 
a-MSH and [Nle4,D-Phe7]-cy-MSH was performed 
in our laboratory and will be described elsewhere. 
[Nle4,D-Phe7]-a-MSH [9] was obtained from 
Bachem, Bubendorf (Switzerland) and cu-MSH 
from Ciba-Geigy Ltd, Basel. Mono-iodinated 
[Nle4,D-Phe7,Trp(Naps)‘]-a-MSH was prepared in 
the dark by the ‘equimolar’ chloramine T method 
[l] and purified by HPLC on a Cl8 reversed-phase 
column using an exponential gradient of 0.1% 
TFA/acetonitrile for elution. 
2.2. Bioassay and binding assay 
Mouse melanoma cells (Cloudman S91 and 
B16-Fl) were cultured as described [lo]. The 
biological activity of the photoreactive peptides 
was determined with the tyrosinase assay using 
cultured S91 cells [ll]. Briefly, 24-well Costar 
tissue culture dishes, containing an initial density 
of 3 x lo4 cells/well, were incubated at 37°C for 
2 days in the presence of 0.2,&i/well of L- 
[3 ’ ,5 ’ -3H]tyrosine (Amersham; > 50 Ci/mmol) 
and serial dilutions of the peptides. [3H]Tyr was 
now removed by treating 1 ml supernatant from 
each well with 50 mg of activated charcoal for 
15 min followed by centrifugation. The amount of 
‘HOH was determined in a P-counter and the 
relative tyrosinase stimulation was calculated from 
the ratio of 3HOH formed by stimulated and con- 
trol groups. 
The receptor binding assay was carried out with 
B16 cell plasma membranes prepared in a similar 
way as described in [12]. The samples (150-200 pg 
protein) were incubated in the dark at 15°C for 3 h 
together with -0.1 ,&i of 1251-labelled [Nle4,D- 
Phe’,Trp(Naps)‘]-cr-MSH and different concentra- 
tions of a-MSH, using a total of 200 ~1 assay buf- 
fer (50 mM Tris-HCl, pH 7.4; 10 mM MgC12; 
1 mM CaC12; 0.3 mM 1, IO-phenanthroline; 1 mM 
dithiothreitol; 0.1% BSA). The samples were then 
diluted with 5 ml of ice-cold buffer, centrifuged at 
48000 x g for 1 h and the pellets counted in a 
y-counter. 
2.3. Photoaffinity labelling 
Photoaffinity experiments with intact S91 cells 
were performed with the apparatus described in 
[6], equipped with an interference filter (365 nm), 
yielding a light intensity of -15 mW/cm2. As op- 
posed to the normal tyrosinase assay, the ceils were 
exposed to 10e7 M peptide solutions for only 1 h in 
the dark and then irradiated for 1 min at 4°C (4 
wells at a time). Unbound hormone was removed 
by thorough washing of the cells which were then 
incubated with [3H]Tyr for 2 days as described 
above. 
Receptor labelling of B16 cell plasma mem- 
branes was carried out as described above for the 
binding assay, except that BSA was replaced by 
thyroglobulin. After preincubation for 3 h at 
15°C the samples were UV-irradiated for 3 min at 
4°C using the whole 310-550 nm spectrum 
(-180 mW/cm’). The samples were then diluted 
with 5 ml ice-cold buffer and centrifuged at 
48000 x g for 1 h. The pellets were solubilized at 
22°C by treatment with urea (SO%)/Triton 
X-lOO/solubilization mixture (62.5 mM Tris-HCl, 
2% SDS, 10% glycerol, 5% mercaptoethanol, 
0.001% bromophenol blue [13]) using a 25 : 1 : 15 
ratio. The proteins were separated by elec- 
trophoresis on 11% SDS polyacrylamide slab gels. 
The autoradiograms were quantified with a gel 
scanner and by reflectometry. 
3. RESULTS 
Photoreactive a-MSH analogues containing 
Apac in position 1 or Naps in position 9 are full 
and equipotent agonists which retain 50% MSH 
activity in the tyrosinase assay (table 1). Attach- 
ment of the more lipophilic Tdbz group to Ser’ 
decreases the potency to about 30% of the parent 
peptide. [Nle4,D-Phe7]-cY-MSH is 120-fold more 
active than a-MSH, and the Naps’ derivative still 
retains a 25-fold higher activity than LU-MSH, thus 
representing the most potent MSH photolabel. 
Photoaffinity labelling of Cloudman S91 cells in 
tissue culture demonstrates that a l-h incubation 
of the cells with photoreactive MSH analogues in 
the dark followed by a 1-min UV-irradiation phase 
at 365 nm and several washes is sufficient to in- 
duce marked stimulation of tyrosinase (fig.1). a- 
MSH (1) without photolabel produces only a 
marginal effect. [Apac-Ser’]-Lu-MSH (2) induces a 
6.5-fold increase of tyrosinase activity, 
[Trp(Naps)‘]-cy-MSH (3) a 10.5-fold and [Tdbz- 
Ser’]-cY-MSH (4) a 13-fold increase as compared to 
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Structure and biological activity of photoreactive wMSH analogues 
Compound” Photolabel Tyrosinase 
stimulation 
ECsob (M) 
1 LU-MSH - 2.5 x 1o-9 
2 [Apac-Ser’]-ru-MSH 4-azidophenylacetyl 5 x 1o-9 
3 [Trp(Naps)‘]-a-MSH 2-nitro-4-azidophenylsulfenyl 5 x 1o-9 
4 [Tdbz-Ser’]-w-MSH 4-(3-trifluoromethyldiazirino)benzoyl 8 x 1o-9 
5 [Nle4,D-Phe7]-Lu-MSH _ 2 x lo-” 
6 [Nle4,D-Phe7,Trp(Naps)‘]- 
cu-MSH 2-nitro-4-azidophenylsulfenyl 1 x lo-‘0 
a Apac and Tdbz are attached to the N-terminus of the molecule, replacing the acetyl 
group. Naps is linked to the 2’-position of the indole moiety of tryptophan 
b Cloudman S91 mouse melanoma cells 
non-irradiated controls. The [Nle4,D-Phe7]-cu- 
MSH analogue (5), which displays exceptional 
receptor affinity, has similar characteristics to 4; 
its photoreactive derivative 6 produces the most 
conspicuous receptor stimulation because of the 
combination of very high initial receptor binding 
and covalent linkage to the receptor. 
Incubation of plasma membranes from B16 
mouse melanoma cells with ‘251-labelled [Nle4,D- 
Phe7,Trp(Naps)‘]-a-MSH followed by UV- 
irradiation, SDS-PAGE and autoradiography 
demonstrated that the radioactivity was localized 
in a single band with a molecular mass -45 kDa 
Fig. 1. Increase in tyrosinase activity after MSH-receptor 
labelling of intact Cloudman S91 melanoma cells with 
different wMSH peptides, as compared to non- 
irradiated controls treated with the same ligand. 
Peptides l-6 are described in table 1. Each bar is the 
Fig.2. Autoradiogram of an SDS-PAGE separation of 
labelled B16 membrane proteins. Left lanes: treatment 
of the membrane pellets as described in section 2; right 
lanes: aggregated MSH-receptor after heating of the 
mean of 8 determinations + SE. pellets in solubilization mixture. 
(fig.2). (B16 cells were preferred for this type of ex- 
periment because of a 5-fold higher receptor con- 
centration than in S91 cells; Siegrist, W. and 
Eberle, A.N., unpublished.) When the samples for 
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Fig.3. (A) Autoradiogram of a competitive labelling 
experiment using a constant amount of ‘251-labelled 
[Nle4,D-Phe’,Trp-(Naps)‘]-cu-MSH and different con- 
centrations of (u-MSH. (B) Quantitative analysis of the 
autoradiogram (0) and comparison with the 
displacement curve in the binding assay using photo- 
MSH as tracer (0). 
the analysis of melanoma cell phosphoproteins 
(+solubilization mixture + heating), the radioac- 
tivity was found at a much higher molecular mass 
due to aggregation of the labelled MSH receptor. 
The specificity of the MSH receptor labelling 
was assessed by comparing the labelling pattern of 
a competitive photoaffinity experiment with the 
binding characteristics of the radioactive photo- 
ligand in a normal binding assay (fig.3). The 
parallel displacement curves in both types of ex- 
periment demonstrate that the labelling of the 
45 kDa protein reflects specific binding of a-MSH 
to melanoma cells. 
4. DISCUSSION 
The biological response of melanoma cells (i.e. 
tyrosinase activation and melanin formation) is 
slow and therefore functional studies with cultured 
cells are more difficult to perform than with the 
rapidly responding melanophores. In addition, the 
cells are very sensitive to UV-light which must be 
filtered (h 2 365 nm) and the irradiation time kept 
as short as possible (Eberle, A.N., unpublished). 
The diazirinophenyl photolabel, originally 
developed by Brunner et al. [14] for membrane 
labelling, is particularly useful for functional 
studies with intact melanoma cells because it is 
more readily photolysed at longer wavelengths 
than the 4-azidophenyl group, resulting in a higher 
labelling efficiency. The lipophilic character of 
[Tdbz-Ser’]-cy-MSH may however give rise to non- 
specific labelling (Eberle, A.N., unpublished). 
For the photoaffinity labelling of MSH recep- 
tors on plasma membranes, the wavelength of the 
UV-light is less critical than the affinity of the pep- 
tide ligand. Therefore, the most potent a-MSH 
analogue, [Nle4,D-Phe’]-a-MSH [9], was chosen 
and a 2-nitro-4-azidophenyl group introduced into 
Trp’ using the Naps-Cl reagent [ 151. This peptide 
was not only more potent than a-MSH but also 
proved to retain excellent bioactivity after 
iodination. 
There is good evidence that the 45 kDa mem- 
brane protein labelled by the radioactive MSH 
photolabel is the MSH receptor or part of it: (i) 
labelling of intact melanoma cells produced a 
biological response, indicating that covalent MSH- 
receptor crosslinking did take place; (ii) non- 
irradiated MSH photolabel was specifically and 
reversibly bound by plasma membranes; (iii) the 
MSH photolabel was only found in the 45 kDa 
band on SDS-PAGE and its covalent insertion was 
competitively inhibited by increasing concentra- 
tions of cu-MSH, in parallel to the curve obtained 
in the binding assay. Preliminary studies (Solca, F. 
and Eberle, A.N., unpublished) indicate that the 
45 kDa protein is a glycoprotein; a varying degree 
of glycosylation could explain the relatively broad 
band on SDS-PAGE. 
The ‘small’ size of 45 kDa for the MSH receptor 
(subunit) is not exceptional as the recent 
characterization of receptor systems for other pep- 
tide hormones revealed molecular mass values of 
30 kDa (renal VZ vasopressin receptor) [ 161, 30 and 
38 kDa (hepatic Vi vasopressin receptor) [ 171 and 
65 kDa (angiotensin II receptor) [ 181. 
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